Jaguar Gene Therapy
Accelerating breakthroughs in gene therapy.
- Business Model
- B2B
- Website
- jaguargenetherapy.com
- Total Funding
- $179.0M
- Last Round
- $139.0M Series BApr 2021
- Rounds
- 2
About
Biotechnology company accelerating breakthroughs in gene therapy for patients with severe genetic diseases.
Summary
Jaguar Gene Therapy is a Biotech company. It has raised $179.0M in total across 2 rounds, most recently a $139.0M Series B round in Apr 2021. Investors include Deerfield Management, Eli Lilly and Company and ARCH Venture Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...